Burke Steven Keith (CIK 0001619834)

Latest company ownership

Role: SVP, Chief Medical Officer
Shares held
809,090
Last filed at
Mar 4, 2025
Confidence Score
50.5
2025Q4
Confidence Score History
2019Q4 2025Q4
Role: SVP and Chief Medical Officer
Shares held
26,332
Last filed at
Mar 18, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 3, 2025 Mar 4, 2025 Akebia Therapeutics, Inc. SVP, Chief Medical Officer Sell 51.3 -7,144 -0.88% $13.1K
Jan 31, 2025 Feb 4, 2025 Akebia Therapeutics, Inc. SVP, Chief Medical Officer Sell 95.0 +144,394 21.49% $106.1K
Aug 25, 2023 May 9, 2024 Akebia Therapeutics, Inc. SVP, Chief Medical Officer Sell 26.3 -27,000 -3.88% $31.1K
Feb 29, 2024 Mar 1, 2024 Akebia Therapeutics, Inc. SVP, Chief Medical Officer Sell 46.3 -7,169 -1.02% $11.3K
Feb 27, 2024 Feb 29, 2024 Akebia Therapeutics, Inc. SVP, Chief Medical Officer Sell 48.8 -8,367 -1.18% $12.7K
Jan 31, 2024 Feb 2, 2024 Akebia Therapeutics, Inc. SVP, Chief Medical Officer Sell 91.3 +177,889 33.34% $40.8K
May 16, 2023 May 18, 2023 Akebia Therapeutics, Inc. SVP, Chief Medical Officer Sell 42.5 -63,567 -10.70% $67.9K
Mar 1, 2023 Mar 3, 2023 Akebia Therapeutics, Inc. SVP, Chief Medical Officer Sell 46.3 -14,123 -2.32% $12.4K
Feb 27, 2023 Mar 1, 2023 Akebia Therapeutics, Inc. SVP, Chief Medical Officer Sell 47.5 -7,539 -1.22% $6.1K
Aug 31, 2022 Sep 1, 2022 Akebia Therapeutics, Inc. SVP, Chief Medical Officer Sell 52.5 -1,147 -0.27% $415.8
Feb 28, 2022 Mar 2, 2022 Akebia Therapeutics, Inc. SVP, Chief Medical Officer Sell 86.3 +44,944 5.78% $32.6K
Aug 31, 2021 Sep 2, 2021 Akebia Therapeutics, Inc. SVP, Chief Medical Officer Sell 50.0 -1,042 -0.60% $2.9K
Apr 1, 2021 Apr 1, 2021 Akebia Therapeutics, Inc. SVP, Chief Medical Officer Sell 50.0 -1,081 -0.63% $3.7K
Feb 26, 2021 Mar 2, 2021 Akebia Therapeutics, Inc. SVP, Chief Medical Officer Sell 91.3 +62,442 63.07% $25.7K
Nov 20, 2019 Nov 22, 2019 Akebia Therapeutics, Inc. SVP, Chief Medical Officer Buy 95.0 +27,000 270.00% $96.7K
Dec 15, 2017 Dec 18, 2017 Protara Therapeutics, Inc. SVP and Chief Medical Officer Buy 86.3 +8,666 7.84% $22.6K